Pharmacokinetics of Levetiracetam (Keppra) in Neonates
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the pharmacokinetic profile of a loading
dose of intravenous levetiracetam, given for clinical reasons, in term and late preterm
infants with seizures. Secondary objectives are to evaluate the safety and efficacy of
levetiracetam in term and preterm infants with seizures.